ResMed, Inc. (RMD)

255.13 -1.16 (-0.45%) USD  |  NYSE  |  Feb 20, 11:10
More

ResMed Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Abbott Laboratories Upgrade
Baxter International, Inc. Upgrade
Stryker Corp. Upgrade
Globus Medical, Inc. Upgrade